ConductScience.org, home

Paper37831776

Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.

Cameron DP and 24 others. Sci Adv, 2023. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription. Papers, record 37831776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37831776

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.
PubMed
Journal
Sci Adv
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2026-09-18
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 25 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Transcription FactorsMajor topic
Humans
Cell Cycle Proteins
Cell Line, Tumor
Nuclear Proteins
Proto-Oncogene Proteins p21(ras)
Transcription, Genetic
DNA Topoisomerases, Type I
Bromodomain Containing Proteins

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42758852Erratum for the Research Article, "Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription" by D. Cameron et al.https://conductscience.org/library/papers/42758852

Source PubMed

Download CSV of comments and corrections

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127364481The role of enhancers in cancer.Nat Rev Cancer2016https://conductscience.org/library/papers/27364481PubMed
226854147Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.Diagnostics (Basel)2015https://conductscience.org/library/papers/26854147PubMed
319451168Fast and accurate short read alignment with Burrows-Wheeler transform.Bioinformatics2009https://conductscience.org/library/papers/19451168PubMed
430967400Exploiting DNA Replication Stress for Cancer Treatment.Cancer Res2019https://conductscience.org/library/papers/30967400PubMed
519141473Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.Genes Dev2008https://conductscience.org/library/papers/19141473PubMed
630686761Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology.Trends Mol Med2019https://conductscience.org/library/papers/30686761PubMed
723396353Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition.Nat Struct Mol Biol2013https://conductscience.org/library/papers/23396353PubMed
816286007Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription.Cell2005https://conductscience.org/library/papers/16286007PubMed
916990856Topoisomerase I inhibitors: camptothecins and beyond.Nat Rev Cancer2006https://conductscience.org/library/papers/16990856PubMed
1016109377Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.Mol Cell2005https://conductscience.org/library/papers/16109377PubMed
1124227677featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.Bioinformatics2014https://conductscience.org/library/papers/24227677PubMed
1217136094Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.Nature2006https://conductscience.org/library/papers/17136094PubMed
1322940375FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.Endocr Relat Cancer2012https://conductscience.org/library/papers/22940375PubMed
1433575621Covering all your bases: incorporating intron signal from RNA-seq data.NAR Genom Bioinform2020https://conductscience.org/library/papers/33575621PubMed
1530146161Transcription Elongation Can Affect Genome 3D Structure.Cell2018https://conductscience.org/library/papers/30146161PubMed
1623786772Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.Cancer Res2013https://conductscience.org/library/papers/23786772PubMed
1728636597Phase separation drives heterochromatin domain formation.Nature2017https://conductscience.org/library/papers/28636597PubMed
1836282862The Next Generation of KRAS Targeting: Reasons for Excitement and Concern.Mol Cancer Ther2022https://conductscience.org/library/papers/36282862PubMed
1928945705Thiol-linked alkylation of RNA to assess expression dynamics.Nat Methods2017https://conductscience.org/library/papers/28945705PubMed
2031123063Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation.Genes Dev2019https://conductscience.org/library/papers/31123063PubMed

See all 117 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42093736Tumor microenvironment responsive nano-immunoregulator for precision cancer photodynamic immunotherapy.Mater Today Bio2026https://conductscience.org/library/papers/42093736PubMed
41298233A Unique Chimeric RNA: ERCC1-iASPP Drives Benzo[a]pyrene-Induced Lung Carcinogenesis via Dual Coding and Non-Coding Mechanisms.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41298233PubMed
41225606Integrative analysis of RNA binding proteins identifies DDX55 as a novel regulator of 3'UTR isoform diversity.Genome Biol2025https://conductscience.org/library/papers/41225606PubMed
41155268Regulatory Mechanisms and Functional Roles of Readthrough Transcripts in Tumorigenesis.Int J Mol Sci2025https://conductscience.org/library/papers/41155268PubMed
40640188Comprehensive resolution and classification of the Epstein Barr virus transcriptome.Nat Commun2025https://conductscience.org/library/papers/40640188PubMed
39520813Temporospatial control of topoisomerases by essential cellular processes.Curr Opin Microbiol2024https://conductscience.org/library/papers/39520813PubMed
39046232Senataxin mediates R-loop resolution on HPV episomes.J Virol2024https://conductscience.org/library/papers/39046232PubMed
38959318Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome.Sci Adv2024https://conductscience.org/library/papers/38959318PubMed
38878530DNA topology: A central dynamic coordinator in chromatin regulation.Curr Opin Struct Biol2024https://conductscience.org/library/papers/38878530PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37831776

GET https://conductscience.org/api/papers/v1/37831776/authors?page=2